LENZ Therapeutics shares third quarter financial results, highlights VIZZ approval and launch November 6, 2025 Categories: Health Care Tags: LENZ Therapeutics
LENZ Therapeutics soars 20.7% after FDA-approved VIZZ launch for presbyopia patients October 3, 2025 Categories: Health Care Tags: LENZ Therapeutics
LENZ secures FDA approval for VIZZ to treat presbyopia August 11, 2025 Categories: Health Care Tags: LENZ Therapeutics
LENZ Therapeutics announces FDA acceptance of new drug application for LNZ100 for the treatment of presbyopia October 28, 2024 Categories: Health Care Tags: LENZ Therapeutics
LENZ Therapeutics announces submission of New Drug Application to FDA for LNZ100 for treatment of presbyopia August 19, 2024 Categories: Health Care Tags: LENZ Therapeutics
LENZ Therapeutics announces completion of merger with Graphite Bio and provides update on recent clinical and corporate progress March 22, 2024 Categories: Health Care Tags: LENZ Therapeutics
LENZ Therapeutics and Graphite Bio announce merger agreement November 16, 2023 Categories: Health Care Tags: LENZ Therapeutics
